Latest From Ventria Bioscience
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.
- Large Molecule
- Synthesis Technologies, Production Processes
- Therapeutic Areas
- Applied Phytologics Inc.
- North America
- Parent & Subsidiaries
- Ventria Bioscience
- Senior Management
Scott E Deeter, Pres. & CEO
Ning Huang, PhD, VP, R&D
Margaret B Glick, PhD, VP, Fin.
Seymour Fein, MD, CMO
- Contact Info
Phone: (970) 818-7010
P.O. Box 273330 Fort Collins, CO 80527
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.